Search
for
Sort by
Research 211–240 of 1000+
- Intrauterine botulinum toxin A administration promotes endometrial regeneration mediated by IGFBP3-dependent OPN proteolytic cleavage in thin endometrium
- Nanotechnology-based techniques for hair follicle regeneration
- Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
- Understanding the Secular Decline in Testosterone: Mechanisms, Consequences, and Clinical Perspectives
- Synopsis: 2005 Annual Meeting of the American Society of Andrology
- E-Poster
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Unveiling the Nuances of Adult Female Acne: A Comprehensive Exploration of Epidemiology, Treatment Modalities, Dermocosmetics, and the Menopausal Influence
- Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management
- Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- The Mechanism of Androgen Actions in PCOS Etiology
- Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016–2023)
- Identification of functional circRNAs regulating ovarian follicle development in goats
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- The Transgender: Endocrinological Assessment
- Polycystic ovary syndrome: Diagnosis and management
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Acne Vulgaris
- Female pattern hair loss: therapeutic update
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- Ovarian surgery for symptom relief in women with polycystic ovary syndrome
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Placental Extracts, Proteins, and Hydrolyzed Proteins as Active Ingredients in Cosmetic Preparations for Hair Loss: A Systematic Review of Available Clinical Evidence
- Three-Month Treatment With a Long-Acting Gonadotropin-Releasing Hormone Agonist of Patients With Benign Prostatic Hyperplasia: Effects on Tissue Androgen Concentration, 5<i>α</i>-Reductase Activity and Androgen Receptor Content*
- Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model
- Impact of One-Week Administration of Dihydrotestosterone in Rat Anterior Pituitary Gland